C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 9/00 (2006.01) A61K 39/145 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2054228
Abstract of the Disclosure Novel murarnyldipeptide derivatives such as [6-0-(2- tetradecylhexadecanoyl)-N--acetylmuramoyl]-L-alanyl-D-glutamamide and [6-0-(2-tetradecylhexadecanoyl)-N-acetylmuramoyl]-L-alanyl-N -methyl- D-glutamamide are provided. The muramyldipeptide derivatives are excellent compound as an adjuvant or a constituting component of virosome vaccine. An influenza vaccine comprises a complex of the muramyldipeptide derivative and an influenza virus antigen. The influenza vaccine has excellent antibody-producing capacity and safety.
Ohkuma Kunio
Oka Tetsuya
Oki Masaharu
Tsuge Hideya
Chemo-Sero-Therapeutic Research Institute (the)
Daiichi Pharmaceutical Co. Ltd.
Swabey Ogilvy Renault
LandOfFree
Muramyldipeptide derivatives and influenza vaccine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Muramyldipeptide derivatives and influenza vaccine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muramyldipeptide derivatives and influenza vaccine... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1996117